Argentina’s cannabidiol market emerged from a grassroots demand for therapeutic alternatives, led initially by patient advocacy groups like Mamá Cultiva, which played a pivotal role in shaping public discourse around medical cannabis. Legal progress began with Law 27.350 in 2017, permitting medical cannabis research and patient access, but it was the 2020 presidential decree under Alberto Fernández that significantly expanded home cultivation rights and enabled regulated access to CBD-based therapies through pharmacies. The earliest clinical applications were focused on pediatric epilepsy at Hospital Garrahan, which relied on imported products from Tilray and Charlotte’s Web until local options emerged. The first nationally produced CBD oil, developed by Cannava in Jujuy, marked a milestone, utilizing ethanol-based extraction under GMP-certified facilities. This oil favored isolate formulations due to strict THC limits, though projects by Agrogenética Riojana and Universidad Nacional de Quilmes have advanced full-spectrum research using CO2 extraction to retain the “entourage effect.” While nanoemulsion-based delivery remains in its infancy, Universidad Nacional de Rosario is piloting such technology in topical formulations. Despite regional legalization waves in Colombia, Mexico, and parts of Europe, Argentina’s cautious stance restricts the use of CBD in food or beverages, with ANMAT adhering to pharmaceutical-grade classification.

These limitations have hindered imports and forced companies to adapt product formulations to comply with local purity and potency standards. Certified labs like CIDCAM conduct third-party testing, although transparency in labelling varies widely among private players. Regulatory inertia has slowed broader commercialization, particularly in cosmetic and wellness categories, where safety concerns over contaminants and unverified products are mounting. The absence of harmonized rules complicates cross-border trade and product registration, especially as international interest grows. While clinical trials by FLENI and Hospital El Cruce investigate long-term CBD efficacy in neurodegenerative diseases, many manufacturers remain in legal limbo, awaiting clearer pathways for scale, innovation, and investment within the evolving legal and scientific framework.According to the research report, "Argentina Cannabidiol Market Research Report, 2030," published by Actual Market Research, the Argentina Cannabidiol market is anticipated to add to more than USD 70 Million by 2025–30.As Argentina’s cannabidiol industry begins to define itself, a mix of public programs and entrepreneurial ventures are setting the tone for expansion despite structural hurdles. Cannava, backed by the Jujuy provincial government, now supplies prescription-based CBD oil across public hospitals and has scaled its cultivation to over 35 hectares, becoming Latin America’s most advanced vertically integrated cannabis operation.

Meanwhile, Agrogenética Riojana launched its therapeutic oil “Conv.I.A.” in collaboration with the state of La Rioja and the National University of La Plata, focusing on full-spectrum cannabinoid content for chronic pain treatment. Private sector momentum is growing through startups like Pampa Hemp and Mediplant, which are positioning themselves with ethanol-extracted oils and terpenes targeting anxiety and muscle recovery. With e-commerce regulations still vague, platforms such as Argencann and direct-to-consumer websites use educational campaigns and virtual consultations to bypass limitations in traditional marketing channels. Pharmacies like Farmacia Goya in Buenos Aires have started dispensing CBD under prescription, helping normalize access and educating consumers. Supply chain vulnerabilities, especially in sourcing GMP-grade hemp and maintaining consistent lab-tested batches, continue to pose challenges for scaling production. The National University of Quilmes is advancing nanoemulsion technology to increase bioavailability in oral drops and sprays, a trend that is attracting interest from pharmaceutical partners like Elea.

Argentina’s cautious yet science-driven approach is shaping a market where regulatory precision is both a barrier and a benchmark, ensuring long-term quality. Strategic alliances, such as Cannava’s deal with Swiss company KannaSwiss, suggest a rising interest in global-standard production. Consumer demand is clearly skewing toward plant-based, organic, and transparent formulations, with personalized blends and QR-coded smart packaging from firms like Cannabis Avanza highlighting a shift toward tech-enabled trust and informed use.In Argentina, the market for oils and tinctures has seen substantial growth, particularly in urban centers like Buenos Aires and Cordoba, where a growing number of consumers are seeking natural remedies for anxiety, stress, and chronic pain. These products are widely available through pharmacies and health stores, making them one of the most accessible and popular forms of cannabidiol in the country. Capsules and softgels are also experiencing increased demand in Argentina, as consumers who prefer a more controlled and consistent dosage of CBD turn to these products. These capsules offer convenience and ease of use, particularly among those who are cautious about measuring out doses with oils or tinctures.

The gummies and confectionery segment is rapidly gaining traction, especially among younger consumers who are looking for a more enjoyable way to incorporate CBD into their daily routines. This form of CBD is not only popular for its taste but also for its perceived benefits in improving mood and relaxation. Additionally, topicals and skin care products infused with CBD are becoming increasingly popular in Argentina, as consumers in major cities are drawn to their potential benefits for skin conditions like acne, psoriasis, and inflammation. The anti-inflammatory and soothing properties of CBD make these products particularly attractive to those seeking alternative skincare solutions. Finally, while vape products have gained some popularity in other markets, their adoption in Argentina is still in the early stages, primarily due to the country's regulations on vaping and smoking. However, as attitudes towards CBD become more liberal, there is potential for growth in this segment, particularly in regions where CBD-related products are gaining acceptance.The wellness and personal use sector in Argentina has become one of the most significant drivers of the cannabidiol market.

With rising awareness around the benefits of natural remedies, many Argentine consumers are turning to CBD as a way to manage anxiety, sleep disorders, and chronic pain. In cities like Buenos Aires and Mendoza, wellness centers and organic health stores are increasingly offering CBD oils and tinctures, contributing to a broader acceptance of cannabidiol as part of a holistic lifestyle. The nutraceuticals and supplements market is also expanding, with CBD being integrated into various health supplements aimed at improving overall well-being. These products are especially popular among health-conscious individuals looking for natural alternatives to pharmaceuticals. The pet care market in Argentina is another emerging area of growth, as more pet owners in Buenos Aires and Rosario turn to CBD-infused products to help manage their pets' anxiety, joint pain, and other health issues. As the understanding of CBD's potential benefits for animals increases, local pet stores are beginning to offer a variety of CBD pet products.

Cosmetics and skincare are gaining popularity, with an increasing number of local beauty brands and international companies offering CBD-infused lotions, serums, and creams. These products are marketed for their potential anti-inflammatory, anti-aging, and skin-soothing benefits, catering to Argentina’s growing beauty-conscious population. In the pharmaceuticals sector, CBD is beginning to make its mark, especially for medical conditions like epilepsy and chronic pain, thanks to Argentina's more progressive stance on medical cannabis. Food and beverages market is beginning to explore the incorporation of CBD, with cafes and health-conscious restaurants in Buenos Aires experimenting with CBD-infused drinks and snacks, catering to a growing consumer base interested in functional foods.In Argentina, marijuana-derived CBD is subject to strict regulation, and while the medical use of cannabis has been legalized in recent years, marijuana-based CBD products remain limited in their availability. The country’s evolving stance on medical cannabis, especially under the framework provided by the National Cannabis Program, has led to increased access for patients suffering from conditions like epilepsy and chronic pain. However, as of now, marijuana-derived CBD products are not as widely available as hemp-derived alternatives.

On the other hand, hemp-derived CBD has found a more prominent position in the Argentine market. Hemp cultivation is legal in the country, and there has been a steady increase in local hemp farming initiatives, particularly in regions like Mendoza and Entre Ríos. As global demand for hemp-based CBD rises, Argentina is positioning itself to become an important player in the hemp industry. The Argentine government has supported the development of domestic hemp production, with ongoing discussions about establishing a robust hemp industry. This is helping local companies meet the rising demand for CBD products while also reducing dependency on international imports. Hemp-derived CBD products are increasingly available across various sectors, from wellness products to skincare, supplements, and pet care.

As the market for hemp-based CBD continues to expand, Argentina is seeing greater opportunities for local businesses to capitalize on both domestic and international demand, and the country’s regulatory environment continues to evolve to facilitate this growth.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cannabidiol Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Form• Oils & Tinctures• Capsules & Softgels• Gummies & Confectionery• Topicals / Skin Care• Vape Products• OthersBy End Use• Wellness & Personal Use• Nutraceuticals & Supplements• Pet Care• Cosmetics & Skin Care• Pharmaceuticals• Food & BeveragesBy Source• Marijuana• Hemp.